The PEARLS Program is a team-based approach, involving counsellors, psychiatrists and medical providers, designed to reduce depressive symptoms and improve quality of life in adults with epilepsy. It was developed by a team at the University of Washington and has been studied through two randomised controlled trials, the second of which measures the long-term benefits of [read the full story…]
This cohort study conducted by researchers from the St. Louis Veterans Affairs Medical Center set out to answer the question: Are antidepressants associated with an increased or decreased risk of incident myocardial infarction and all-cause mortality? 93,653 patients aged 25–80 years (average age 51.5 years, 14.1% female, 77.8% White, 57.1% not married) were identified using the [read the full story…]
Treating depression is rarely straightforward, but treating someone who is depressed and also has comorbid personality disorders can be even more complicated. Studies have shown that short-term psychodynamic psychotherapy (STPP) is a treatment worth considering for depression and personality disorders when they occur individually, but this intervention has not yet been studied systematically for people [read the full story…]
This systematic review conducted by the UK National Collaborating Centre for Mental Health set out to review the efficacy of non-pharmacological treatment for depression in people with depression and chronic physical health problems. They found 35 RCTs that met their inclusion criteria and ended up conducting a meta-anlalysis of 22 studies using a random-effects model. The bulk [read the full story…]
A new meta-analysis published in the British Journal of Psychiatry has found that people with mental health problems are significantly less likely to receive important cardiac treatment (revascularisation, angiography, angioplasty and bypass grafting) following a cardiac event. People with mental illness experience a 14% lower rate of invasive coronary interventions following a cardiac event and [read the full story…]
Patients with coronary heart disease are susceptible to depression and this comorbidity makes cardiovascular outcomes worse. Using antidepressants to treat depression in patients with other health conditions is sometimes quite controversial. This meta-analysis looked at the health effects of selective serotonin reuptake inhibitors (SSRIs) versus placebo or no antidepressants in patients with coronary heart disease [read the full story…]
Depression has a habit of attaching itself to lots of health problems, not just for the patient, but also sometimes for carers and other family members. This systematic review and meta-analysis looks at the association between activity restriction and depression in medical patients and their caregivers. The review found a clear positive relationship between lack [read the full story…]
